Exploring the human microbiome from multiple perspectives: factors altering its composition and function
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Our microbiota presents peculiarities and characteristics that may be altered by multiple factors. The degree and consequences of these alterations depend on the nature, strength and duration of the perturbations as well as the structure and stability of each microbiota. The aim of this review is to sketch a very broad picture of the factors commonly influencing different body sites, and which have been associated with alterations in the human microbiota in terms of composition and function. To do so, first, a graphical representation of bacterial, fungal and archaeal genera reveals possible associations among genera affected by different factors. Then, the revision of sequence-based predictions provides associations with functions that become part of the active metabolism. Finally, examination of microbial metabolite contents and fluxes reveals whether metabolic alterations are a reflection of the differences observed at the level of population structure, and in the last step, link microorganisms to functions under perturbations that differ in nature and aetiology. The utilisation of complementary technologies and methods, with a special focus on metabolomics research, is thoroughly discussed to obtain a global picture of microbiota composition and microbiome function and to convey the urgent need for the standardisation of protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 2×
“Faecalibacterium is depleted during inflammatory conditions (Sokol et al. 2008) and plays an important role in inducing regulatory T cells (Sarrabayrouse et al. 2014) and decreasing intestinal permeability (Laval et al. 2015).”
BackgroundProteobacteria: Microbial signature of dysbiosis in gut microbiota
Shin, N.-R., Whon, T. W., & Bae, J.-W. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.011 · Cited by 3,954
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
The Placenta Harbors a Unique Microbiome
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008599 · Cited by 2,494 · cited 4×
“to the gut microbiota, which is themost extensively studied, because multiple community types at several body sites are interconnected and/or enriched in similar types of microorganisms (Aagaard et al. 2014; Ding and Schloss 2014; Urbaniak et al. 2014).”
BackgroundInfluentialPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · cited 5×
“By focusing on the gut microbiota, a recent study revealed that 14 out of 664 genera conforms the core microbiota (Falony et al. 2016).”
BackgroundInfluentialPopulation-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914 · cited 2×
“A recent study undertaking in-depth sequencing of the gut microbiomes of 1135 participants found that the use of antibiotics was significantly associated with microbiota composition alterations (Zhernakova et al. 2016).”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 4×
“2013), ulcerative colitis (Machiels et al. 2014), colon cancer (Ou et al.”
BackgroundInfluentialComposition, variability, and temporal stability of the intestinal microbiota of the elderly
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000097107 · Cited by 1,754
Potential of fecal microbiota for early-stage detection of colorectal cancer
Zeller, G., Tap, J., Voigt, A. Y., Sunagawa, S., Kultima, J. R., Costea, P. I., Amiot, A., Böhm, J., Brunetti, F., Habermann, N., et al. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145645 · Cited by 1,375
Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation
Browne, H. P., Forster, S. C., Anonye, B. O., Kumar, N., Neville, B. A., Stares, M. D., Goulding, D., & Lawley, T. D. (2016) · Nature · doi:10.1038/nature17645 · Cited by 1,299
Persistent gut microbiota immaturity in malnourished Bangladeshi children
Subramanian, S., Huq, S., Yatsunenko, T., Haque, R., Mahfuz, M., Alam, M. A., Benezra, A., DeStefano, J., Meier, M. F., Muegge, B. D., et al. (2014) · Nature · doi:10.1038/nature13421 · Cited by 1,270
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Vandeputte, D., Falony, G., Vieira-Silva, S., Tito, R. Y., Joossens, M., & Raes, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309618 · Cited by 1,028
Characterization of the gut microbiome using 16S or shotgun metagenomics
Jovel, J., Patterson, J., Wang, W., Hotte, N., O'Keefe, S., Mitchel, T., Perry, T., Kao, D., Mason, A. L., Madsen, K. L., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00459 · Cited by 942
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930 · cited 6×
“…the samples, thus partially solving the issue related to different consistency and water content in the faecal material (Jacobs et al. 2008; Duboc et al. 2012, 2013; Phua et al. 2013; Weir et al. 2013; Sheflin et al. 2015; Vanden Bussche et al. 2015; Abdulkadir et al. 2016; Dior et al.…”
BackgroundInfluentialDe Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · cited 6×
“For example, about 38 metabolites associated to pervasive developmental disorder (De Angelis et al. 2013), 24 to liver cirrhosis (Cao et al. 2011; Huang et al. 2013), 14 to SLE (Rojo et al. 2015b) and 12 to type 2 diabetes mellitus (Zhu et al. 2014) (Fig.”
BackgroundInfluentialDynamics and associations of microbial community types across the human body
Ding, T., & Schloss, P. D. (2014) · Nature · doi:10.1038/nature13178 · Cited by 885 · cited 4×
“We do not restrict the review to the gut microbiota, which is themost extensively studied, because multiple community types at several body sites are interconnected and/or enriched in similar types of microorganisms (Aagaard et al. 2014; Ding and Schloss 2014; Urbaniak et al. 2014).”
BackgroundInfluentialGreenblum, S., Turnbaugh, P. J., & Borenstein, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116053109 · Cited by 821
Xenobiotics shape the physiology and gene expression of the active human gut microbiome
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013) · Cell · doi:10.1016/j.cell.2012.10.052 · Cited by 811
Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696 · cited 1×
“…Parabacteroides, Bacteroides fragilis, Sutterella and Lachnospiraceae with volatile organic compounds such as 4-methyl-2-pentanone, 1-pentanol, 1-butanol and 2-butanone are characteristic of patients with paediatric non-alcoholic fatty liver disease and obesity (Del Chierico et al. 2017).”
BackgroundFunctional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
Moya, A., & Ferrer, M. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.02.002 · Cited by 690 · cited 10×
“…absorbed and/or produced by the action of the microbiota are the downstream products of gene and protein expression, whose quantification has been demonstrated to be the most reliable snapshot of changes in metabolic perfor- mance of the microbiota under any condition (Moya and Ferrer 2016).”
BackgroundInfluentialSelf-citationOu, J., Carbonero, F., Zoetendal, E. G., DeLany, J. P., Wang, M., Newton, K., Gaskins, H. R., & O’Keefe, S. J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056689 · Cited by 646
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults
Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070803 · Cited by 642 · cited 13×
“For example, an association with colorectal cancer was found for 78 faecal metabolites (Monleón et al. 2009; Ou et al. 2013; Weir et al. 2013; Goedert et al. 2014; Bjerrum et al. 2015; Wang et al. 2015; Sinha et al. 2016), 36 are associated with gastrointestinal disease cryptosporidiosis (Ng et al.”
BackgroundInfluentialThe contributory role of gut microbiota in cardiovascular disease
Tang, W. H. W., & Hazen, S. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72331 · Cited by 641
Metabolomics enables precision medicine: “A White Paper, Community Perspective”
for “Precision Medicine and Pharmacometabolomics Task Group”-Metabolomics Society Initiative, Beger, R. D., Dunn, W., Schmidt, M. A., Gross, S. S., Kirwan, J. A., Cascante, M., Brennan, L., Wishart, D. S., Oresic, M., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1094-6 · Cited by 592
Biesbroek, G., Tsivtsivadze, E., Sanders, E. A. M., Montijn, R., Veenhoven, R. H., Keijser, B. J. F., & Bogaert, D. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1240oc · Cited by 572 · cited 2×
“…(Grice and Segre 2011), the mucosa (Moen et al. 2016), the gastrointestinal tract (Claesson et al. 2011; Falony et al. 2016), the respiratory tract (Biesbroek et al. 2014), the urinary tract (Whiteside et al. 2015), the vagina (Martin 2012), the mammary gland (Urbaniak et al. 2014) or the placenta…”
BackgroundMicrobiota of Human Breast Tissue
Urbaniak, C., Cummins, J., Brackstone, M., Macklaim, J. M., Gloor, G. B., Baban, C. K., Scott, L., O'Hanlon, D. M., Burton, J. P., Francis, K. P., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.00242-14 · Cited by 552
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
Vernocchi, P., Del Chierico, F., & Putignani, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01144 · Cited by 426
Weingarden, A. R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V. M., Sadowsky, M. J., & Khoruts, A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00282.2013 · Cited by 423
Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults
Tap, J., Furet, J., Bensaada, M., Philippe, C., Roth, H., Rabot, S., Lakhdari, O., Lombard, V., Henrissat, B., Corthier, G., et al. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.13006 · Cited by 397 · cited 2×
“biotic exposure (Maurice, Haiser and Turnbaugh 2013; Ursell and Knight 2013) and dietary interventions such as plant-based diets (Ni, Li and Panagiotou 2015; Tap et al. 2015) and vitamin B12 supplementation (Kang et al.”
BackgroundIntegrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease
Erickson, A. R., Cantarel, B. L., Lamendella, R., Darzi, Y., Mongodin, E. F., Pan, C., Shah, M., Halfvarson, J., Tysk, C., Henrissat, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049138 · Cited by 395
Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing
Vogtmann, E., Hua, X., Zeller, G., Sunagawa, S., Voigt, A. Y., Hercog, R., Goedert, J. J., Shi, J., Bork, P., & Sinha, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0155362 · Cited by 366 · cited 3×
“…been found altered in HIV-infected individuals (Vázquez-Castellanos et al. 2015) as well as in patients with colorectal cancer (Zeller et al. 2014; Vogtmann et al. 2016), non-alcoholic fatty liver disease (Michail et al. 2015), type 1 diabetes (Consortium 2012), inflammatory bowel disease…”
BackgroundAltered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease
Michail, S., Lin, M., Frey, M. R., Fanter, R., Paliy, O., Hilbush, B., & Reo, N. V. (2015) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiu002 · Cited by 336
Chen, P., Torralba, M., Tan, J., Embree, M., Zengler, K., Stärkel, P., van Pijkeren, J.-P., DePew, J., Loomba, R., Ho, S. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.014 · Cited by 322 · cited 1×
“Their quantification has laid the foundation for studying associations with diet interventions (Kibe et al. 2014, Chen et al. 2015, De Leoz et al. 2015; Sheflin et al. 2015), antibiotic treatments (Ng et al. 2013), surgical and dietary weight loss (Damms-Machado et al. 2015), and diseases such as…”
BackgroundUniversality of human microbial dynamics
Bashan, A., Gibson, T. E., Friedman, J., Carey, V. J., Weiss, S. T., Hohmann, E. L., & Liu, Y.-Y. (2016) · Nature · doi:10.1038/nature18301 · Cited by 270 · cited 2×
“tics that can be altered due to the genetic background, diseases, diet and interaction with the environment (Bashan et al. 2016; Noecker et al. 2017).”
BackgroundBikel, S., Valdez-Lara, A., Cornejo-Granados, F., Rico, K., Canizales-Quinteros, S., Soberón, X., Del Pozo-Yauner, L., & Ochoa-Leyva, A. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.06.001 · Cited by 263 · cited 3×
“…and analysis was developed to reveal associations between common perturbations and microbial functions in humans, by means of exploring links with altered gene content and expression, protein synthesis andmetabolite production (Bikel et al. 2015; Abreu and Taga 2016; Aguilar-Pulido et al. 2016).”
BackgroundDuboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01893.x · Cited by 256 · cited 9×
“…the samples, thus partially solving the issue related to different consistency and water content in the faecal material (Jacobs et al. 2008; Duboc et al. 2012, 2013; Phua et al. 2013; Weir et al. 2013; Sheflin et al. 2015; Vanden Bussche et al. 2015; Abdulkadir et al. 2016; Dior et al.…”
BackgroundInfluentialCerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study
Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Sawaki, E., Koga, Y., & Benno, Y. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00009 · Cited by 227 · cited 2×
“…also as a measure of health status, as metabolites produced by the microbiota are neurotransmitters controlling the bidirectional gut– brain axis (Matsumoto et al. 2013), helping to maintain and repair the large intestine (Kibe et al. 2014), and playing a crucial role in controlling intestinal…”
BackgroundDifferential Effects of Antibiotic Therapy on the Structure and Function of Human Gut Microbiota
Pérez-Cobas, A. E., Artacho, A., Knecht, H., Ferrús, M. L., Friedrichs, A., Ott, S. J., Moya, A., Latorre, A., & Gosalbes, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080201 · Cited by 212 · cited 11×
“Indeed, well-established methods and commercially available kits are available to isolate DNA and cDNA from our microbiota (for recent examples, see Hampton-Marcell et al. 2013; Pérez-Cobas et al. 2013b; Reck et al. 2015; Bashiardes, Zilberman-Schapira and Elinav 2016; Moen et al. 2016).”
BackgroundMethodInfluentialMetabolite profiling of fecal water extracts from human colorectal cancer
Monleón, D., Morales, J. M., Barrasa, A., López, J. A., Vázquez, C., & Celda, B. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1345 · Cited by 186 · cited 3×
“…with autoimmune disease (Rojo et al. 2015b), celiac disease (Sellitto et al. 2012), chronic kidney disease (Poesen et al. 2016), colorectal cancer (Monleón et al. 2009; Ou et al. 2013; Weir et al. 2013; Goedert et al. 2014; Bjerrum et al. 2015; Wang et al. 2015; Sinha et al. 2016), non-alcoholic…”
BackgroundThe active human gut microbiota differs from the total microbiota
Peris-Bondia, F., Latorre, A., Artacho, A., Moya, A., & D'Auria, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022448 · Cited by 113 · cited 1×
“This is because they also take into account dormant, dead and quiescent bacteria, as they are also present in any sample (Peris-Bondia et al. 2011; Gosalbes et al. 2012; Potgieter et al. 2015).”
BackgroundInstability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83 · cited 1×
“…difficile infection (Džunková, D’Auria and Moya 2015; Džunková et al. 2016), Crohn’s disease and irritable bowel syndrome (Duboc et al. 2012, 2013; Durbán et al. 2013; Rehman et al. 2016; Valles-Colomer et al. 2016), non-alcoholic fatty liver disease (Michail et al. 2015), HIV infection…”
Background
Cited by
Plant Microbiome Engineering: Expected Benefits for Improved Crop Growth and Resilience
Arif, I., Batool, M., & Schenk, P. M. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.04.015 · Cited by 447
The Human Microbiome and Its Impacts on Health
Ogunrinola, G. A., Oyewale, J. O., Oshamika, O. O., & Olasehinde, G. I. (2020) · International Journal of Microbiology · doi:10.1155/2020/8045646 · Cited by 442
Hooks, K. B., & O’Malley, M. A. (2017) · mBio · doi:10.1128/mbio.01492-17 · Cited by 382
Castro-Bravo, N., Wells, J. M., Margolles, A., & Ruas-Madiedo, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02426 · Cited by 284
The role of the gut microbiota in the metabolism of polyphenols as characterized by gnotobiotic mice
Pasinetti, G. M., Singh, R., Westfall, S., Herman, F., Faith, J., & Ho, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171151 · Cited by 112
Metadata
- Authors
- Rojo, D., Méndez-García, C., Raczkowska, B. A., Bargiela, R., Moya, A., Ferrer, M., & Barbas, C.
- Venue
- FEMS Microbiology Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-25
- Volume
- 41
- Issue
- 4
- Pages
- 453-478
- ISSN
- 0168-6445 (ISSN-L)
- 1574-6976
- OpenAlex
- W2653295461
- Cited by
- 157
- References
- 45
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.